DI-INDO

They stem from the anti-inflammatory activity of indomethacin, the importance of the intolerance manifestations to which the medicine gives rise, and its place within the range of anti-inflammatory products currently available.

In adults (over 15 years), they are limited to:

· long-term symptomatic treatment:

o of chronic inflammatory rheumatism, notably rheumatoid arthritis, ankylosing spondylitis,

o of certain disabling and painful arthroses;

· short-term symptomatic treatment of acute flare-ups of:

o abarticular rheumatism (scapulo-humeral peri-arthritis, tendinitis, bursitis),

o microcrystalline arthritis,

o severe radiculalgias,

o arthroses.

Warn patients of the possible onset of drowsiness, dizziness and visual disturbances.